tobramycin has been researched along with cefmenoxime in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adelman, MH; Nix, DE; Schentag, JJ | 1 |
Aoyama, H; Izawa, Y; Nishizaki, A; Okuda, J | 1 |
Bryskier, A; Husson, MO; Izard, D; Leclerc, H; Vincent, P | 1 |
Dalla Costa, T; Derendorf, H | 1 |
Ohashi, Y; Suzuki, T | 1 |
Eguchi, H; Hattori, T; Hoshi, S; Inoue, H; Inoue, T; Miyamoto, H; Nejima, R; Ohashi, Y; Suzuki, T; Todokoro, D | 1 |
6 other study(ies) available for tobramycin and cefmenoxime
Article | Year |
---|---|
Mathematical examination of dual individualization principles (I): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycin.
Topics: Cefmenoxime; Ciprofloxacin; Computer Simulation; Kinetics; Microbial Sensitivity Tests; Models, Theoretical; Tobramycin | 1991 |
Optimal conditions for injection of tobramycin and cefmenoxime into burn patients.
Topics: Adult; Aged; Bacterial Infections; Burns; Cefmenoxime; Cefotaxime; Female; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Tobramycin | 1987 |
Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Netilmicin; Species Specificity; Tobramycin | 1984 |
AUIC--a general target for the optimization of dosing regimens of antibiotics?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefmenoxime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Models, Biological; Tobramycin | 1996 |
Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefmenoxime; Corneal Ulcer; Drug Combinations; Drug Synergism; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Pseudomonas; Quinolines; Staphylococcus; Streptococcus; Tobramycin | 2013 |
Clinical Characteristics and Bacteriological Profile of Moraxella Keratitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefmenoxime; Child; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Eye Injuries; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella; Moraxellaceae Infections; Retrospective Studies; Risk Factors; Tobramycin | 2015 |